These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Intravitreal triamcinolone and elevated intraocular pressure. Wingate RJ; Beaumont PE Aust N Z J Ophthalmol; 1999 Dec; 27(6):431-2. PubMed ID: 10641903 [TBL] [Abstract][Full Text] [Related]
31. [Incidence and risk factors of intraocular pressure elevation after triamcinolone acetonide administration for macular disorders]. Ito T; Nozaki M; Ogura Y Nippon Ganka Gakkai Zasshi; 2006 May; 110(5):379-83. PubMed ID: 16764319 [TBL] [Abstract][Full Text] [Related]
32. Pars plana vitrectomy with internal limiting membrane peeling compared with intravitreal triamcinolone injection in the treatment of diabetic macular edema. Kim YM; Chung EJ; Byeon SH; Lee SC; Kwon OW; Koh HJ Ophthalmologica; 2009; 223(1):17-23. PubMed ID: 18849632 [TBL] [Abstract][Full Text] [Related]
33. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Thompson JT Am J Ophthalmol; 2006 Apr; 141(4):629-37. PubMed ID: 16564796 [TBL] [Abstract][Full Text] [Related]
34. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Hirano Y; Sakurai E; Yoshida M; Ogura Y Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753 [TBL] [Abstract][Full Text] [Related]